Mosaic ImmunoEngineering Inc.
CPMV· OTC
CPMVMosaic ImmunoEngineering Inc.
Filed Aug 3, 2023 · 10-Q · 34 days after period end · 0001683168-23-005245
| Metric | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|
| Net Income | $19.61K | -$929.63K | -$979.42K | -$511.00 |
| EPS Diluted | $0.00 | -$0.13 | -$0.14 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Mosaic ImmunoEngineering Inc. · CIK 836564 · Engraved from SEC EDGAR
ended Jun 30, 2023 · filed Aug 3, 2023 · 34 d after period end
